Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Bone Mass Loss in Postmenopausal Women With Lumbar Spine Osteopenia (PREPEMO)
2007-001030-13Phase 4Active
- Sponsor
- IMAS
- Start
- Oct 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Osteogenon, calcium carbonate in osteopenia, osteoporosis, sponsored by IMAS. Started Oct 2009; status: active.
02
Drugs
Osteogenoncalcium carbonate
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on 2007-001030-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001030-13.